The role of xerostomia in burning mouth syndrome: a case-control study

Arquivos de Neuro-Psiquiatria

Luciana Alvarenga Da Silva¹  José Tadeu Tesseroli De Siqueira¹  Manoel Jacobsen Teixeira¹  Silvia Regina Dowgan Tesseroli De Siqueira¹ 

关键词: xerostomia;    salivary flow;    orofacial pain;    quantitative sensory testing;    burning mouth syndrome;    xerostomia;    fluxo salivar;    dor orofacial;    teste sensitivo quantitativo;    síndrome ardência bucal;   

DOI  :  10.1590/0004-282X20130218

来源: SciELO

【 摘 要 】

Objective : To assess the efficacy of anti-xerostomic topical medication (urea 10%) in patients with burning mouth syndrome (BMS). Method : Thirty-eight subjects diagnosed with BMS according to the International Association for the Study of Pain guidelines were randomized to either placebo (5% sodium carboxymethylcellulose, 0.15% methyl paraben, and 10% glycerol in distilled water qsp 100 g) or treatment (urea 10%) to be applied to the oral cavity 3-4 times per day for 3 months. The patients were evaluated before and after treatment with the following instruments: the EDOF-HC protocol (Orofacial Pain Clinic – Hospital das Clínicas), a xerostomia questionnaire, and quantitative sensory testing. Results : There were no differences in salivary flow or gustative, olfactory, or sensory thresholds (P>0.05). Fifteen (60%) patients reported improvement with the treatments (P=0.336). Conclusion : In conclusion, there were no differences between groups, and both exhibited an association between reported improvement and salivation.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License